Brief: Heartbeam Completes $25 Million Capital Raise And Updates 2023 Strategic Focus And Financial Guidance
03/05/2023 13:54
May 3 (Reuters) - Heartbeam Inc BEAT.O :
* HEARTBEAM COMPLETES $25 MILLION CAPITAL RAISE AND UPDATES
2023
STRATEGIC FOCUS AND FINANCIAL GUIDANCE
* HEARTBEAM INC: EXPECT NO MATERIAL COMMERCIAL REVENUE FOR
2023
* HEARTBEAM INC: ADJUSTED ITS STRATEGIC FOCUS TO ENABLE
TIMELY
DELIVERY OF ITS BREAKTHROUGH AMBULATORY VECG PRODUCTS
* HEARTBEAM INC - PLANS TO SUBMIT 510(K) CLEARANCE FOR
12-LEAD
EQUIVALENCE TO FDA IN LATE 2023 & PURSUE INITIAL
COMMERCIALIZATION IN 2024
Source text for Eikon: ID:nBw4fv40ca
Further company coverage: BEAT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heartbeam
See all newsBrief: Heartbeam Announces Strategic Shift To Accelerate Global Adoption Of Its Ambulatory ECG Signal Platform And Leadership Transition
Brief: Heartbeam Reports First Quarter 2026 Results
HeartBeam Q1 net loss narrows as commercialization advances
Brief: Heartbeam Initiates Pilot Study Of First On-Demand 12-Lead ECG Patch To Detect Ischemia Outside The Clinic
Brief: Heartbeam Expands Commercial Presence Across Four Key U.S. Markets With Addition Of Premier Concierge Practice